10/23/2013
https://congress.gov...
"Look, no physician wants to tell a patient that they cannot receive the care they need because there is no treatment but because the product is simply not available and we won't provide alternatives i..."
"Statement, dated February 7, 2012, of the Biotechnology Industry Organization, submitted by Mr. Pitts."
"A lot of folks where I come from, they can't afford a $50 substitute for a $20 product that they have been taking for way too many years."
"the strong risk aversion at the FDA is creating at least the perception that it is slowing down or stopping the approval of new, innovative treatments for cancer and other life-threatening terminal di..."